Streetbeat News

Analyst Ratings

SKX

Piper Sandler analyst Abbie Zvejnieks maintains a Neutral rating on Skechers USA (NYSE:SKX) and raises the price target from $52 to $54.

Portfolio Pulse from Benzinga Newsdesk

July 28, 2023 | 5:51 pm

SKX

Wedbush analyst Tom Nikic maintains an Outperform rating on Skechers USA (NYSE:SKX) and raises the price target from $58 to $59.

Portfolio Pulse from Benzinga Newsdesk

July 28, 2023 | 5:50 pm

MDLZ

Piper Sandler analyst Michael Lavery maintains an Overweight rating on Mondelez International (NASDAQ:MDLZ) and raises the price target from $82 to $83.

Portfolio Pulse from Benzinga Newsdesk

July 28, 2023 | 5:48 pm

SAM

Wedbush analyst Gerald Pascarelli has maintained a Neutral rating on Boston Beer Co (NYSE:SAM) and raised the price target from $325 to $350.

Portfolio Pulse from Benzinga Newsdesk

July 28, 2023 | 5:47 pm

OTLY

Piper Sandler analyst Michael Lavery maintains an Overweight rating on Oatly Group (NASDAQ:OTLY) but lowers the price target from $4 to $3.

Portfolio Pulse from Benzinga Newsdesk

July 28, 2023 | 5:46 pm

ENPH

Piper Sandler analyst Kashy Harrison maintains an Overweight rating on Enphase Energy (NASDAQ:ENPH) but has lowered the price target from $210 to $180.

Portfolio Pulse from Benzinga Newsdesk

July 28, 2023 | 5:44 pm

LUV

Southwest Airlines Co (NYSE:LUV) has been downgraded by Raymond James analyst Savanthi Syth from Strong Buy to Outperform, with a price target cut from $47 to $40. The company reported a 4.6% YoY operating revenue growth to $7.04 billion in Q2 FY23, beating consensus. However, the recovery to 2019-level profitability has been pushed from 2024 to 2025. Other analysts from TD Cowen, Barclays, and Deutsche Bank also lowered their price targets for LUV.

Portfolio Pulse from Anusuya Lahiri

July 28, 2023 | 5:43 pm

DECK

Stifel analyst Jim Duffy maintains a 'Buy' rating on Deckers Outdoor (NYSE:DECK) and raises the price target from $550 to $600.

Portfolio Pulse from Benzinga Newsdesk

July 28, 2023 | 5:43 pm

DXCM

Piper Sandler analyst Matt O'Brien maintains an Overweight rating on DexCom (NASDAQ:DXCM) and raises the price target from $150 to $160.

Portfolio Pulse from Benzinga Newsdesk

July 28, 2023 | 5:39 pm

ABBV

Piper Sandler analyst Christopher Raymond has maintained an Overweight rating on AbbVie (NYSE:ABBV) and raised the price target from $163 to $170.

Portfolio Pulse from Benzinga Newsdesk

July 28, 2023 | 5:38 pm